These miniature immune system models -- known as human immune organoids -- mimic the real-life environment where immune cells learn to recognize and attack harmful invaders and respond to vaccines.

A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...

To better understand why some cancer patients struggle to fight off infections, Georgia Tech researchers have created tiny lab-grown models of human immune systems. These miniature models -; known as ...

Revenue: Revenue for the three months ended September 30, 2024, increased to approximately $1,958,000 compared to $397,000 ...

Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...

The age of Homo technicus could generate profound intellectual advances and solutions to our gravest problems. But first we ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Dr Humphrey Mabwi’s groundbreaking work explores the intricate relationship between gut health and mental well-being ...

James Fickel has dedicated $200 million he made betting on Ether to becoming one of the world’s biggest investors in those ...

NOTES TO EDITORS About STORM Therapeutics STORM Therapeutics is a clinical-stage biotechnology company pioneering cellular ... is the first RNA modifying enzyme inhibitor to enter human clinical ...